Venous thromboembolism: A clinician update.
Anticoagulants
/ administration & dosage
Clinical Decision-Making
Fibrinolytic Agents
/ administration & dosage
Hemorrhage
/ chemically induced
Humans
Patient Selection
Recurrence
Risk Assessment
Risk Factors
Thrombolytic Therapy
/ adverse effects
Time Factors
Treatment Outcome
Venous Thromboembolism
/ blood
acute management of VTE
deep vein thrombosis (DVT)
post-thrombotic syndrome
pulmonary embolism (PE)
venous thromboembolism (VTE)
Journal
Vascular medicine (London, England)
ISSN: 1477-0377
Titre abrégé: Vasc Med
Pays: England
ID NLM: 9610930
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
entrez:
6
4
2019
pubmed:
6
4
2019
medline:
29
5
2019
Statut:
ppublish
Résumé
Venous thromboembolism (VTE) is a common vascular condition. New medications are available to prevent hospital-associated VTE. Strategies are being studied to increase appropriate diagnostic testing utilization. Management of deep vein thrombosis (DVT) and pulmonary embolism (PE) has evolved with the advent of new anticoagulant options and catheter-directed intervention. In light of this, providers are commonly challenged with the decision regarding inpatient versus outpatient management. Which patients require long-term (> 3 months) anticoagulation is challenging and multiple clinical prediction models may be used to help determine the risk-benefit ratio in each patient. The management of VTE is an ongoing area of research and is rapidly evolving.
Identifiants
pubmed: 30950331
doi: 10.1177/1358863X18821159
doi:
Substances chimiques
Anticoagulants
0
Fibrinolytic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM